Brooks Automation Announces Fiscal 2021 Third Quarter Earnings Conference Call and Webcast

Brooks Automation Announces Fiscal 2021 Third Quarter Earnings Conference Call and Webcast

CHELMSFORD, Mass., July 20, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 third quarter which ended on June 30, 2021 on Thursday, August 5, 2021 after the market closes.

The Company will host a conference call and live webcast to discuss its financial results on the same day, Thursday, August 5, 2021 at 4:30 p.m. Eastern Time.  To participate in the conference call, please dial 800-941-1366 for domestic callers and +1-212-231-2926 for international callers.

Analysts, investors and members of the media can access the live webcast via the Brooks website at https://brooks.investorroom.com/events.  A replay will be available beginning at 8:30 a.m. ET on August 6, 2021.

About Brooks Automation
Brooks (Nasdaq: BRKS) operates two, global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise.  The Company’s Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry’s top pharmaceutical, biotech, academic and healthcare institutions globally.  Brooks Life Sciences’ GENEWIZ division is a leading provider of gene sequencing and gene synthesis services.  With over 40 years as a partner to the semiconductor manufacturing industry, Brooks’ Semiconductor Solutions business provides industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world’s leading semiconductor chip makers and equipment manufacturers as well as collaborative robotics and automation capabilities for multi-market applications. 

On May 10, 2021, Brooks announced its plans to separate into two, independent publicly traded companies by establishing a standalone life sciences company, comprised of the Life Sciences business and a standalone automation company, comprised of the Semiconductor Solutions business. The transaction is expected to be completed by the end of calendar year 2021.

Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, visit www.brooks.com.

INVESTOR CONTACTS:
Sara Silverman
Director, Investor Relations
Brooks Automation
978.262.2635
sara.silverman@brooks.com

Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com

Brooks_Automation_Logo

SOURCE Brooks Automation